NEW YORK, March 3, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Charles River Laboratories International, Inc. CRL following allegations that Charles River has disclosed potentially materially misleading business information to the investing public.

SO WHAT: If you have purchased Charles River securities, you may be entitled to compensation without payment of out-of-pocket expenses or costs through a contingency fee arrangement. Law firm Rosen is preparing a class action lawsuit to recover investor losses.

WHAT TO DO NEXT: To participate in the prospective class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=12403 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email pkim@rosenlegal.com or cases@rosenlegal.com for information about the Class Action.

WHAT IS THIS ABOUT: On February 22, 2023, Charles River announced that it had received a grand jury subpoena for documents related to a joint investigation by the US Department of Justice (“DOJ”) and the US Fish and Wildlife Service (“USFWS”) into the illegal importation of received non-human primates from Cambodia for research purposes, which has already led to criminal charges against two Cambodian officials and a Cambodian supplier of non-human primates. The company said it would voluntarily stop shipping primates from Cambodia, which could affect the company’s ability to source nonhuman primates for research. In addition, she warned that the investigation could hurt her business.

As a result of this news, Charles Rivers stock price fell by as much as 15% during intraday trading on February 22, 2023, hurting investors.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Many of these firms don’t actually litigate securities…